Future Scope of Electrical Hospital Beds Market is Witness to Grow High CAGR till 2023

 Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Electrical Hospital Beds Market Research Report – Forecast to 2023” Gives industry size, top players and worldwide demand

Global Electrical Hospital Beds Market Research Report: by Type (Semi-automatic, Automatic), by Treatment (Critical Care, Acute Care, Long Term Care), by Application (General Purpose, Psychiatric), by End-user (Hospitals & Clinics, Reproductive Care Centers, Dentistry, Home Care), and Region – Forecast to 2023

The Global Electrical Hospital Beds Market is likely to attain a valuation of USD 2,595.4 Mn at a CAGR of 7.25% by the end of the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an in-depth study. Electrical hospital beds are of paramount importance to patients with reduced mobility. Patients with acute disease conditions such as paralysis, spinal injuries, and others have witnessed a surge in number in recent years, and electrical hospital beds are increasingly gaining traction among such patients. Electrical hospital beds can be operated with minimal assistance and are of great help to ailing patients. Medical emergency units generate a high demand for electrical hospital beds since medical emergency rooms experience an influx of patients with severe medical ailments.

Also Read : https://www.medgadget.com/2019/04/electrical-hospital-beds-market-projected-to-grow-radiantly-at-18-cagr-by-2023-medline-industries-inc-getinge-ab-arjohuntleigh-stryker-corporation-etc.html

A growing number of accidents, wars, and natural calamities have prompted hospitals to delegate more space for emergency rooms which has further induced demand for electrical hospital beds. Furthermore, the government in multiple countries are revamping their healthcare sector which is providing a boost to the growth of the electrical hospital beds market. Technological advancements which result in improvising of electrical hospital beds and consequently leads to the increased sale of electrical hospital beds. On the flipside, the growth of electrical hospital beds market might be deterred by high costs and high maintenance costs.

Key Players :

Market Research Future (MRFR) recognizes the following companies as the key players in Electrical Hospital Beds Market: There are plenty of large and small market players which operate in this market all over the globe.

The eminent players in the global electrical hospital beds market include Span America Medical System, Inc. (U.S.), Paramount Bed Holding Co., Ltd. (Japan), Famed Zywiec Sp.zo.o. (Poland), Hill Room Holding (U.S.), Stryker Corporation (U.S.), Invacare Corporation (U.S.), Amico Group of Companies (Canada), Medline Industries, Inc. (U.S.), Getinge AB (Sweden), ArjoHuntleigh (Sweden), Malvestio Spa (Italy), Midmark Corporation (U.S.), Merivaara Corporation (Finland), Gendron, Inc. (U.S.), and Linet spol.s.r.o. (Czech Republic).

Segments :

The global electrical hospitals beds market has been segmented based on type, type of treatment, application, and end user.

By type, the global electrical hospital beds market has been segmented into semi-automatic bed and fully automatic bed. The fully automatic beds segment currently stands at USD 1,029 Mn and is likely to scale up to USD 1,570.9 Mn by 2023 and capture the highest CAGR of 8.83% over the forecast period. Semi-automatic beds segment is likely to strike a CAGR of 5.07% over the forecast period.

By type of treatment, the global electrical hospital beds market includes critical care, acute care, and long-term care. The critical care segment is the largest as well as the fastest growing segment and is expected to expand at a CAGR of 8.03% over the forecast period to scale valuation of USD 1,020.6 Mn. The acute care segment is expected to be the second largest segment and is expected to attain USD 865.4 Mn by 2023.

By application, the global electrical hospital beds market has been segmented into general purpose, intensive care, delivery/birthing, bariatric, pediatric, pressure relief, psychiatric care, and others. The general purpose segment is leading the market and is expected to reach a market valuation of USD 836.4 Mn by 2023 with a CAGR of 7.29% over the forecast period. The intensive care segment is expected to be the fastest growing segment and capture a CAGR of 7.82% over the forecast period.

By end-user, the global electrical hospital beds market has been segmented into hospital & clinics, reproductive care centers, dentistry, home, & others. Hospitals & clinics segment is dominating the market and is expected to expand at a CAGR of 7.25% over the forecast period.  However, homecare segment is expected to be the fastest growing segment and register a CAGR of 8.81% over the forecast period.

Regional Analysis :

By region, the global electrical hospital beds market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).

Europe is the largest market for electrical hospital beds and accounted for 34% share of the global market in 2017. Presence of sophisticated healthcare infrastructure and greater emphasis on patient health and comfort in the region drives the market. The U.K., France, and Germany are the key contributors to the Europe market which can scale valuation of USD 906.4 Mn by the end of 2023.

The Americas is the second largest market for electrical hospital beds driven by high healthcare spending in strong economies such as the US and Canada.

APAC market is anticipated to exhibit rapid growth over the forecast period. High investment on the development of healthcare infrastructure, the growth of medical tourism and availability of a massive patient pool creates favorable growth opportunities for the market growth. The APAC market is estimated to strike a CAGR of 8.47% over the forecast period.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/electrical-hospital-beds-market-6552

Paraneoplastic Syndrome Market – A market with high CAGR and return on investment by 2023

 Market Research Future adds the “Paraneoplastic Syndrome Market Research Report – Forecast to 2023” report to their unique collection.

Paraneoplastic Syndrome Market Highlights:

Schizophrenia is a chronic and severe mental disorder that affects the thinking, feeling, and behavior of the A paraneoplastic syndrome is a set of signs and symptoms which develops from tumor or cancer. This syndrome can be mostly seen in middle-aged to older patients and are often seen in patients suffering from breast cancer, lung cancer, and lymphatic or ovarian cancer. Sometimes, patients with paraneoplastic syndrome do not show symptoms even after the diagnosis, but there exists a rare condition where patients show symptoms of the paraneoplastic syndrome even before diagnostic tests are carried out.

The global paraneoplastic syndrome market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position.

Also Read : https://www.medgadget.com/2019/01/paraneoplastic-syndrome-market-outlook-2023-in-depth-research-on-diagnostics-treatment-and-management-development-prospective-report-2019.html

Paraneoplastic Syndrome Market: The increasing prevalence of cancer and tumor-related problems is projected to boost the market growth during the forecast period from 2018 to 2023

Factors such as the increasing prevalence of cancer, awareness regarding breast cancer, and an unhealthy lifestyle drive the growth of the global paraneoplastic syndrome market. Moreover, rising investments in research and development activities and increasing healthcare expenditure are few more factors driving the global paraneoplastic syndrome market.

On the other hand lack of awareness regarding cancer and stringent regulations may hamper the growth of the market.

Comprehensive Regional Analysis

The Americas is anticipated to dominate the global paraneoplastic syndrome market. The market growth in this region is attributed to the increasing geriatric population with paraneoplastic syndrome disorder, investment in research and development, and technological advancements.

Europe is expected to be the second largest market in the globe owing to the increasing number of geriatric population, increasing awareness regarding breast cancer, the presence of disposable income, and increasing consumption of tobacco in this region.

Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of paraneoplastic syndrome and cancer-related problems in developing countries, increasing disposable income, and growing healthcare expenditure.

The Middle East and Africa is expected to account for the lowest market share in the global paraneoplastic syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.

Intended Audience

• Hospitals and clinics
• Laboratories and associations
• Healthcare providers
• Research institutes and academic centers
• Government associations
• Market research and consulting

Competitive Analysis by Major Key Players

Some of the key players in the global paraneoplastic syndrome market are Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation.

Industry Segmentation

The global paraneoplastic syndrome market has been segmented into types, diagnosis, treatment, and end users. Based on types, the market is segmented into the cutaneous paraneoplastic syndrome, gastro-intestinal paraneoplastic syndrome, endocrine paraneoplastic syndrome, hematologic paraneoplastic syndrome, renal paraneoplastic syndrome, rheumatologic paraneoplastic syndromes, and neurologic paraneoplastic syndrome.

The market, by treatment, has been segmented into medication and therapies. Medication is further sub-segmented into corticosteroids, immunosuppressants, anti-seizure medications, plasmapheresis, and intravenous immunoglobulin (IVIg). On the basis of therapies, the market is further sub-segmented into physical therapy and speech therapy.

The market on the basis of diagnosis has been segmented into blood test, spinal tap (lumbar puncture), and imaging tests. Imaging tests are further sub-segmented into computerized tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and PET plus CT.

Based on end-user, the market is segmented into hospitals and clinics, diagnostic centers, and ambulatory care centers.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/paraneoplastic-syndrome-market-6524

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

PEGylated drugs Market – Product Development is the best strategy for market position; Forecast till 2023

 Recently MRFR, a leading market research firm collated a novel report on “Global PEGylated drugs Market Research Study” that gives comprehensive market overview about the current market dynamics with a focus on the worldwide market.

PEGylated Drugs Market Analysis

The global PEGylated drugs market is expected to exhibit a solid 5.53% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global PEGylated drugs market is expected to reach a valuation of USD 13.5 billion by 2025. The major drivers and restraints affecting the global PEGylated drugs market are profiled in the report to provide readers with a clear overview of the major factors determining the movement of the market. This provides readers with a clear overview of the movement of the market. The historical growth trajectory of the global PEGylated drugs market is also assessed in the report, along with forecasts for the market’s movement over the forecast period.

Also Read : https://www.medgadget.com/2020/06/coronavirus-covid-19-impact-on-pegylated-drugs-market-2020-global-industry-analysis-merger-demand-overview-growth-rate-swot-analysis-top-leaders-forecast-to-2025.html 

PEGylation is the addition of a polyethylene glycol polymer to bioactive molecules such as proteins, peptides, enzymes, and others. The addition of PEG increases the efficacy of the bioactive molecules by making the molecule less detectable by the body’s immune system. It also increases the size of the molecule in a solution, increasing the amount of time before the renal system detects and excretes it. Hydrophobic drugs and molecules are also made water-soluble by PEGylation, which is a key factor driving the global PEGylated drugs market. Growing awareness about these benefits of PEGylation is likely to drive the global PEGylated drugs market.

Due to the growing awareness of the benefits of PEGylation, many leading companies are investing in PEGylation, leading to a more widespread interest in the process in the healthcare and life sciences sectors. Due to this significant investment, many companies have PEGylated molecules in the pipeline. Several PEGylated drugs have received FDA clearance and many are in the testing phase currently. On the other hand, adverse reactions to PEGylated drugs and consequent recalls are likely to be the major restraint on the global PEGylated drugs market over the forecast period.

PEGylated Drugs Market Competitive Leaderboard:

Leading players in the global PEGylated drugs market include Bayer AG, Takeda Pharmaceutical Company Ltd., Merck & Co. Inc., AstraZeneca, Amgen Inc., UCB SA, Novo Nordisk A/S, Pfizer Inc., F. Hoffman-La Roche Ltd., and Horizon Therapeutics plc. Leading players in the global PEGylated drugs market are focusing on product launches at the moment, as the regulatory environment is ripe for new product launches.

PEGylated Drugs Market Segmentation:

The global PEGylated drugs market is segmented on the basis of molecule, indication, and region.

By molecule, the global PEGylated drugs market is segmented into proteins, FAB fragments, enzyme, aptamers, and others. The proteins segment holds a dominant 64.8% share in the global PEGylated drugs market and is likely to remain in the driving seat over the forecast period due to the growing interest in PEGylated proteins.

By molecule, the global PEGylated drugs market is segmented into cancer, gout, hemophilia, hepatitis, and others.

PEGylated Drugs Market Regional Analysis:

The Americas hold a dominant share of 65.73% share in the global PEGylated drugs market. The strong position of the healthcare and life sciences sectors in North America is the major driver for the PEGylated drugs market in the Americas. Growing investment in PEGylated drugs is likely to result in steady growth of the market in the region over the forecast period. North America, led by the U.S., is the dominant regional market within the Americas and is likely to remain the dominant force over the forecast period. The rising prevalence of cancer in the region and the growing demand for effective drugs against the same is likely to be a major driver for the PEGylated drugs market in North America. The rising prevalence of hemophilia is also a major driver for the PEGylated drugs market.

Europe holds the second largest share in the global PEGylated drugs market. The rising occurrence of cancer in Europe is the major driver for the global PEGylated drugs market. Western Europe, comprising France, the UK, Germany, etc. is the dominant regional segment within Europe.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pegylated-drugs-market-8436 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Metabolomics Services Market Poised to Witness a Significant Growth by 2023

 Metabolomics Services Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

Metabolomics Services Market Analysis

The metabolomics services market size is predicted to touch USD 16,291.0 million at a 7.77% CAGR between 2016-2025, reveals the new Market Research Future (MRFR) report. Metabolomics is a study of unique chemical processes that are inside the cells and involves metabolites. This collection of metabolites in its entirety in an organism, organ, tissue, or biological cell is known as metabolome. These are the final products of cellular processes. Metabolomics is widely used in personalized medicine, functional genomics, nutrigenomics, toxicology testing, drug discovery, metabolomics profiling services such as biomarker discovery, among others.  

Also Read : https://www.medgadget.com/2020/04/metabolomics-services-market-size-to-touch-usd-16291-0-million-at-7-77-cagr-by-2025.html 

Numerous factors are adding to the metabolomics services market demand. Such factors, as revealed by the latest MRFR report, include increasing application in the biotechnological and life science industry, technological advances in instrumentation, and increasing incidence of diseases like cardiac diseases, neurological disorders, and cancer worldwide. Additional factors adding to the metabolomics services market share include the growing necessity for toxicology testing, burgeoning demand for personalized medicine, and rising biotech & pharmaceutical research and development expenditure.

On the contrary, strict government regulations/policies and high instrument cost are factors that may limit the metabolomics services market growth over the forecast period.

Metabolomics Services Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the metabolomics services market based on application and product & service.

By product & service, the metabolomics services market is segmented into mass spectrometry, metabolomics bioinformatics services, and chromatography. Chromatography is a method used in the laboratory to separate a mixture. It is of four types- paper chromatography, thin-layer chromatography, gas chromatography, and liquid chromatography. Bioinformatic tools and services are needed to perform essential functions like database functionalities and statistical analyses. It also helps researchers to decide that metabolites that are most meaningful biologically. Mass spectrometry is an advanced method to determine a compound’s molecular weight. Of these, metabolomics bioinformatics services will lead the market over the forecast period for its tremendous progress that is predicted to grow further for the use of parameter estimation techniques and robust algorithms in life-science analysis and research.

By application, the metabolomics services market is segmented into food, agriculture, biomedical, and pharmaceutical.

Metabolomics Services Market Regional Analysis

By region, the global metabolomics services market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will spearhead the market over the forecast period for the increasing incidence of cardiovascular diseases and cancer.

The global metabolomics services market in Europe is predicted to hold the second-largest share over the forecast period for the constant innovations in medical devices to augment the quality of life, increasing healthcare expenditure, and the presence of several top medical device companies in the region.

The global metabolomics services market in the APAC region is predicted to grow at a quick pace over the forecast period. Factors adding to the global metabolomics services market growth in the region include entry of leading companies, especially in developing countries, increase in R&D centers, growing disposable income, rising number of research and development organizations, and emerging healthcare infrastructure.

The global metabolomics services market in the MEA is predicted to have a small share during the forecast period for lack of adequate healthcare infrastructure and low per capita income.

Metabolomics Services Market Key Players

Leading players profiled in the global metabolomics services market report include Shimadzu Corporation (Japan), Human Metabolome Technologies America Inc. (Japan), Metabolon, INC (US), Creative Proteomics (US), Biocrates Life Sciences AG (Austria), Thermo Fisher Scientific (US), TMIC (Canada), Bruker (US), Agilent Technologies, Inc. (US), and Waters (US).

Metabolomics Services Industry News

March 2020: Regenr8 has joined hands with Physician’s Lab of Boca Raton to develop the first-ever epigenetic analysis- Epigenetic Biomarker Profile for determining the impact on an individual’s environment on his/her unique gene function by using the advanced diagnostic capabilities of the Physicians Lab for identifying different metabolites created from the enzymatic and metabolic cellular processes of tested individuals. This advanced metabolomic diagnostics will offer assessments of sleep markers, key vitamin markers, neurotransmitter metabolites, and much more.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/metabolomics-services-market-8435 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Pain Relief Medication Market – Product Development is the best strategy for market position; Forecast till 2023

 Pain Relief Medication Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Pain Relief Medication Market-Overview

The need for pain relief has skyrocketed, primarily due to a combination of lifestyle and environmental factors. The healthcare reports are made by Market Research Future, which includes market options for progress. A 4.73% CAGR is predicted to urge the progress of the market in the forecast period.

Also Read : https://www.marketwatch.com/press-release/pain-relief-medication-market-to-exhibit-a-473-cagr-by-2025-covid-19-impact-analysis-size-estimation-global-share-growth-top-company-profile-merger-2020-08-14 

The innovations in product efficacy that lead to the availability of a string product are estimated to promote the overall development of the market of pain relief medications. The cancer segment is estimated to appear as the leading segment that will be benefitted from the advances in product development being carried out by market contenders. Moreover, the applications in diabetic nerve pain and fibromyalgia are foreseen to influence the global market progress in the forecast period.

Pain Relief Medication Market Segmental Analysis 

The segmental assessment of the pain relief medication market has been carried out based on indication, drug class, regions, and distribution channel. Based on drug class, the pain relief medication market has been segmented into opioids, COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, and others. On the basis of indication, the pain relief medication market is segmented into neuropathic pain, cancer pain, musculoskeletal pain, inflammatory conditions, and others. Based on the distribution channel, the pain relief medication market has been segmented into pharmacies, hospitals, and retail, and online pharmacies. Based on the region, the pain relief medication market is segmented into Asia-Pacific, the Middle East, Europe, the Americas, and Africa.

Pain Relief Medication Market Regional Analysis 

The regional overview of the pain relief medication market is segmented into Asia-Pacific, the Middle East, Europe, the Americas, and Africa. The Americas regions are projected to be the principal market due to the augmentation in prolonged ailments in this region. In the national market of Brazil, chronic pain is an extensive clinical complaint. The European region’s pain relief medication market is estimated to diversify due to the presence of big contenders in the market who also have a solid global standing in the market. Owing to the upswing in initiatives by the public & private establishments, the pain relief medication market in the Asia-Pacific is anticipated to be the fastest-growing region overall. The pain relief medication market in the Middle East & Africa is projected to show notable development in terms of demand enhancement in the course of the forecast period.

Pain Relief Medication Market Competitive Analysis

The demand curves and growth pace are not estimated to pick up immediately and will require the presence of several key factors that can boost the sentiment in the global market. The reinforcement in the delivery chains is likely to enforce an optimistic effect on the market.  Though, the competition in the market, though pronounced, is estimated to create a conducive outlook for the market. The investments in the market are also estimated to gain traction at a steady pace in the foreseeable future. Government backing is estimated to have a more important role in building the economy, and this is estimated to be extended to the development of this market as well. The dynamic elements in the market are estimated to contribute to the development process extensively. Also, the long term development in the market is estimated to follow the pattern of a staggered pace rather than a continuous development plan. The companies in the market are observed as being more cautious in their long term forecasting while accounting for unprecedented factors.

The formidable contenders in the pain relief medication market are Allergan plc (Ireland), Boehringer Ingelheim International GmbH (Germany), Bayer (Germany), Biogen Idec (US), Bristol-Myers Squibb (US), Eli Lilly and Company (US), AbbVie Inc. (US), Mallinckrodt Pharmaceuticals (UK), Pfizer, Inc. (US), Astellas Pharma Inc. (Japan), Purdue Pharma (US), GlaxoSmithKline (UK), Sanofi (France), and Teva Pharmaceutical Industries Ltd (Israel).

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/pain-relief-medication-market-8431 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

 

Light Therapy Market Projected to Witness Vigorous Expansion by 2023

 Light Therapy Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

Light Therapy Market has an opportunity to scale a growth valuation of USD 1,112.16 Million by 2025 with a moderate CAGR of 5.1% in the forecast period that covers 2019 to 2025. Market Research Future (MRFR) considers the rising number of dermatological disorders as the major reason behind the market growth of the light therapy market. Among other major reasons, growing demand for non-invasive methods, treatment for psychological disorders, and better funding for research and development projects are deemed to play crucial roles in taking the market forward.

However, side-effects like eye pain, nausea, headache, itching, burning sensation, and agitation can deter the market from having a smooth run. Its lack of awareness in several countries can also hold back the growth.

Also Read : https://www.medgadget.com/2019/12/light-therapy-market-size-to-worth-over-us-1112-16-million-in-terms-of-revenue-by-2019-to-2025-industry-share-trends-growth-demand-finds-mrfr.html

Light Therapy Market Leaders

The market for light therapy is witnessing a surge in strategic moves that ensure market growth. This would depend much on the performance of the market players like

• BioPhotas (US)
• Beurer (Germany)
• Northern Light Technology (Canada)
• Koninklijke Philips (Netherlands)
• Verilux (US)
• Nature Bright (Taiwan)
• Chal-Tec GmbH (Germany)
• Lumie (UK)
• Lucimed SA (Belgium)
• Zepter International (Switzerland)

and others. These companies have their recent moves profiled by MRFR to understand the market movements in a proper way.

Recently, the FDA approved Revian Red dual-wavelength LED light therapy (PhotonMD) for the treatment of hair loss, which can boost the market considerably.

 Light Therapy Market Segmentation

The global Light Therapy Market has been segmented in the report on the basis of product, application, light type, and end user.

By product, the market for light therapy can be segmented into lightbox, floor & desk lamp, light visor, dawn simulator, handheld devices for skin treatment (HDST), light therapy bulbs, and others. The ‘others’ segment would include Bluewave technology and light on a timer. The HDST segment has the largest market share as patients prefer this for its ability to cope up with the home care setting. The light visor setting is the fastest-growing segment and its portability is playing in favor of the market.

By application, the global market report on the light therapy can be segmented into psoriasis, vitiligo, eczema, acne vulgaris, sleeping disorders, seasonal affective disorder (SAD), and others that include bone injuries and joint pain. The sleeping disorder segment has the widest market coverage and psoriasis has the opportunity to register the fastest growth rate for the foreseeable future.

By light type, the market report focusing on the study of light therapy segments the market into blue light, white light, red light, and others. The blue light segment covers the widest portion of the market as its takers are growing to treat sun damage and skin cancer. The red light has the fastest growth rate and its application to treat joint pain and arthritis is growing. The ‘others’ include purple light and yellow light.

By end user, the report segments the market into homecare settings, dermatology clinics, and others. The home care setting covers the maximum ground as it is cost affordable. The ‘others’ segment includes workplace and salons.

 Light Therapy Market Regional Analysis

The Americas is showing great progress owing to the huge demand it is getting from the rising demand for non-invasive procedures. In addition, the regional market has a great opportunity in getting the market horizon expanded by increasing the number of treatments done for dermatological problems with light therapy. In Europe, the growth of this segment would be substantial as several countries like France, Germany, the UK, and others would show growth in their reception of the light therapy. This would happen mostly due to increasing awareness and spending capacity.

The Asia Pacific region would benefit from the number of people seeking therapy with this to counter their psychological issues. Growth in a number of people having trouble with depression and anxiety can increase the chance for the light therapy market growth. In the Middle East & Africa, the market would suffer from a lack of awareness regarding both dermatological and psychological issues and poor investment capacity.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/light-therapy-market-8366

About Market Research Future:

Market Research Future® has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Contact Us:

Market Research Future (MRFR)

528, Amanora Chamber

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Future Growth of Spectral Computed Tomography Market is Expected to Grow Healthy CAGR till 2023

 Global Spectral Computed Tomography Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Global Spectral Computed Tomography Market – Overview

Spectral Computed Tomography provides a precise analysis of the Computed tomography (CT), an x-ray scanning technique used as a prominent medical imaging device, serving as a workhorse in many clinical settings worldwide. CT addresses the need for urgent diagnostic tasks such as tumor staging, oncology, and radiation therapy planning or acute stroke analysis.

Also Read : https://www.medgadget.com/2018/06/spectral-computed-tomography-market-2018-perceives-heavy-growth-with-a-substantial-cagr-of-7-8-by-types-spiral-ct-electron-beam-tomography-etc-avail-at-mrfr.html  

Spectral Computed Tomography has changed the spectrum of diagnostics and treatments of many diseases, which acts as a key driving force has increased the market size of Spectral CT on the global platform. Increasing prevalence of the chronic diseases such as cancer, cardiac, orthopedic and neurological diseases, is the major driving factor for the market growth.

Acknowledging the traction, the market is vibrating with; Market Research Future (MRFR) in its recently published study report asserts that the globalSpectral Computed Tomography market gaining further prominence will register a spectacular growth by 2023 posting ~ 7% CAGR during 2017 – 2023.

Factors such as favorable reimbursement policies, coupled with the ongoing product development & commercialization help boosting the market growth. CT has been evolved as one of the most important imaging technique in various medical applications. Hence, increasing applications of CT and rising approval from regulatory bodies account for the predominant factors, fueling the market growth.

Increasing incidence of chronic diseases fuelled by the changing and sedentary lifestyle are increasing the demand for CT, expanding the market growth of Spectral Computed Tomography. Therefore, the market perceives a considerable expansion. Technological advancements that took place in the field of medical science is also one of the key factors fostering the market growth.

Besides, efforts & investments transpired into the R&D activities by the key market players for the development of new devices, are paying off well, fueling the market growth. Concurrently, government initiatives are playing a significant role in the growth of the market.

On the other hand, factors such as the high procedural cost of Spectral CT devices along with the skepticism of physicians towards the advancement & efficacies of these devices are likely to impede the growth of Spectral Computed Tomography market. Also, the reported cases of adverse effects of the X-rays coupled with the requirement of training are some of the factors, presenting challenges to the market growth during the assessment period. Nevertheless, the demand for sophisticated devices by the physicians and patients, in turn, is contributing to the market growth to a great extent.

Top Players:

The Global Spectral Computed Tomography Market is led by some of the fervent players including Agilent Technologies (US), Thermo Fisher Scientific (US), Koninklijke Philips N.V. (Netherlands), General Electric Company (US), Neusoft Medical Systems (Russia), Pall Corporation (US), Xoran Technologies, LLC (US), Hitachi medical corporation (Japan), Varian Medical Systems, Inc. (US), Siemens Healthcare Private Limited (Germany), Trivitron Healthcare (US), PerkinElmer Inc. (US), Cleaver Scientific Ltd (UK), Bio-Rad Laboratories, Inc. (US), NeuroLogica Corp (US), iCAD Inc. (US), Shimadzu Corporation (Japan) and Shenzhen Anke High-tech Co., Ltd. (China). Profiling them in its analysis, MRFR finds out their strategies keeping them at the forefront of competition.

Global Spectral Computed Tomography Market – Competitive Analysis

Spectral Computed Tomography market appears to be competitive & fragmented owing to the presence of several matured & small key players forming a competitive landscape. Strategic partnership, expansion, acquisition, product & technology launch, and collaboration remain the key strategies of market players to achieve competitive advantage.

Industry/Innovation/Related News:

June 8, 2018 – Royal Philips (the Netherlands), leading global player in health technology in collaboration with the SAM (Singapore Institute of Advanced Medicine) Holdings officially opened the AMI center (Advanced Medicine Imaging) at Biopolis (Singapore), an international biomedical research hub. Apart from providing the specialized oncology care, scientific R&D, and medical training for the up-skilling the region’s healthcare professionals, the new facility is equipped with Philips’ IQon Spectral CT, a new generation Computed Tomography (CT) and another world-first solution at AMI.

Global Spectral Computed Tomography Market – Segmentations

MRFR has segmented the market into four key dynamics for the convenience of the report and enhanced understanding;

By Types: Spiral CT, Electron Beam Tomography, Multi-Slice Computed Tomography, Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography among others.

By Application: Oncology, Neurology, Cardiology, Spine, Musculoskeletal Disorders, Body Imaging, and Gastrointestinal Diseases among others.

By End Users: Diagnostic Centers, and Hospitals among others.

By Regions: Europe, North America, APAC and Rest of the World.

Global Spectral Computed Tomography Market – Geographical Analysis

The North America market is expected to dominate the global Spectral Computed Tomography market with the significant market share. Growing prevalence of cardiovascular diseases, cancer and orthopedic diseases in the region are driving the market growth.

Moreover, factors such as increasing demand for minimally invasive procedures, technologically advanced treatment and products along with the rising healthcare expenditures and government support, are expected to drive the regional market growth commutatively. Also, the presence of the leading players is one of the predominant factors propelling the market growth in the region.

Whereas the Europe & Asia Pacific markets in terms of the market share stand at the second & third positions respectively. The Europe market is expected to demonstrate a healthy growth during the forecast period. The market growth attributes to the factors such as the availability and accessibility of advanced treatment facilities & healthcare expenditures along with the growing demand for better healthcare infrastructure.

Moreover, rising rates of cardiovascular diseases along with the rising geriatric populace, growing population increasingly inclined towards the sedentary lifestyle, such factors are driving the regional market growth. Rampant funding support from the private and public bodies for R&D activities is propelling the growth of the Spectral Computed tomography market in the European region.

The Asia-Pacific emerging as a lucrative market for SCT is expected to register the fastest growth for Spectral Computed Tomography. Factors such as growing incidences of neurovascular diseases coupled with the availability of new treatment methods and the growing population that is increasingly gaining awareness towards the excellent healthcare drive the market in the region.

The Middle East & Africa own a tiny share in the global Spectral Computed Tomography market. Reason being the least contribution, mainly from Africa due to the poor economy, low per capita healthcare expenditure and stringent government policies.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com